Drawing for CETARGIN

USPTO serial 87559493

CETARGIN

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
DIXON, JENNIFER HAZARD
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CETARGIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Alumit

JOHN ALUMIT ALUMIT IP135 S. JACKSON STREET, SUITE 200GLENDALE, CA 91205UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Amino acids for medical purposes; Amino acids for veterinary purposes; Depuratives for the body; Dietary supplements for animals; Dietetic beverages adapted for medical purposes; Dietetic foods adapted for medical use; Digestives for pharmaceutical purposes; Food for babies; Glucose for medical purposes; Immunostimulants; Infant formula; Medicinal drinks; Nutraceuticals for use as a dietary supplement; Nutritional supplements; Opotherapy preparations; Pharmaceutical preparations for reducing hepatic encephalopathy, for correcting metabolic disorders, for improving microcirculation in the liver, and for antioxidation; Pharmaceutical preparations for improving cardiovascular system functions, for improving microcirculation and vasodilation, for reducing blood pressure, for preventing atherosclerotic changes, for reducing cholesterol levels, for alleviating endothelial dysfunction, for increasing the level of physical load, and for reducing athenia and over fatigue; Pharmaceutical preparations for skin care; Syrups for making meal replacement beverages adapted for medical use; Albumin dietary supplements; First aid kits; Glucose dietary supplements; Medical preparations for slimming purposes; Medicinal hair growth preparations; Preparations for the treatment of burns; Sodium salts for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 16, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 16, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 24, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 22, 2019EX3GSOU EXTENSION 3 GRANTED—
Jul 22, 2019EXT3SOU EXTENSION 3 FILED—
Jul 22, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 9, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 7, 2019EX2GSOU EXTENSION 2 GRANTED—
Feb 7, 2019EXT2SOU EXTENSION 2 FILED—
Feb 7, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 28, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 26, 2018EX1GSOU EXTENSION 1 GRANTED—
Jul 26, 2018EXT1SOU EXTENSION 1 FILED—
Jul 26, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 13, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 19, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 19, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 29, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 9, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 9, 2017DOCKASSIGNED TO EXAMINER—
Aug 11, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 11, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance